-  This bill is not active in this session.
 
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

J00843 Summary:

BILL NOJ00843
 
SAME ASNo Same As
 
SPONSORRIVERA
 
COSPNSR
 
MLTSPNSR
 
 
Go to top

J00843 Text:

 
Senate Resolution No. 843
 
BY: Senator RIVERA
 
        MEMORIALIZING  Governor  Kathy  Hochul to proclaim
        June 2025, as Meningitis B Awareness  Month  in  the
        State of New York
 
  WHEREAS,  It  is  the  custom  of  this Legislative Body to increase
awareness of serious illnesses that affect the lives  of  our  citizens;
and
 
  WHEREAS,  It  is  the  sense of this Legislative Body to memorialize
Governor Kathy Hochul to proclaim June 2025, as Meningitis  B  Awareness
in the State of New York, in conjunction with the observance of National
Meningitis Month; and
 
  WHEREAS,   Meningococcal  disease,  more  commonly  referred  to  as
bacterial meningitis, is any infection caused by the bacterium Neisseria
meningitidis; and
 
  WHEREAS,  Meningococcal  disease  is  uncommon;  however,  when   it
strikes, its flu-like symptoms make diagnosis difficult; and
 
  WHEREAS,  Meningococcal  disease  can  cause serious illness such as
infection of the lining of the brain and spinal column  (meningitis)  or
blood  infections  (sepsis); the disease strikes quickly and can lead to
severe or permanent disabilities, such as hearing  loss,  brain  damage,
seizures, limb amputation or even lead to death within 24-48 hours; and
 
  WHEREAS, Although 1 in 10 people are carriers for this bacteria with
no  signs  or  symptoms  of  disease,  sometimes  Neisseria meningitidis
bacteria can cause illness; and
 
  WHEREAS,  There  are  different  strains  of  bacterial  meningitis,
including  serogroups  A,  C,  W,  Y,  and B, and vaccines exist to help
provide protection against all  the  serogroups  commonly  seen  in  the
United States; and
 
  WHEREAS,  The  single best way to help prevent all common strains of
meningococcal disease is to be vaccinated with both  a  MenACWY  vaccine
and a separate MenB vaccine; and
 
  WHEREAS,  Meningococcal  disease is spread from person to person via
the exchange of the bacteria through respiratory and  throat  secretions
during  close  or  lengthy  contact, such as sharing beverages or eating
utensils, kissing, or spending time in close contact with someone who is
sick or who carries the bacteria; and
 
  WHEREAS, Community settings in which large groups of people  gather,
like   college  campuses,  can  increase  the  risk  of  the  spread  of
meningococcal disease; and
 
  WHEREAS, Because of the way  meningitis  is  spread,  through  close
personal  contact,  and  that  the  social behavior of young adults ages
16-23 increases their risk  of  contracting  the  disease;  students  in
 
dormitory  settings  and  crowded events, are particularly vulnerable to
meningococcal disease; and
 
  WHEREAS,  While  vaccines  for  serogroups  A, C, W, and Y have been
available for  many  years,  prior  to  2014,  there  were  no  vaccines
available for serogroup B; and
 
  WHEREAS,  Despite the existence of a serogroup B vaccine, meningitis
B has been responsible for all U.S. college campus outbreaks since 2011,
with some cases resulting in death; and
 
  WHEREAS, Because the B strain of meningitis requires a new, separate
vaccination, students heading to college may mistakenly  think  that  if
they  received  the  MenACWY vaccine that they are protected against all
strains and may not realize they are not protected against the B strain;
and
 
  WHEREAS, According to the Centers  for  Disease  Control,  Neisseria
meningitidis   serogroup  B  accounts  for  approximately  half  of  all
meningococcal cases among persons aged 16-23 years in the U.S.; and
 
  WHEREAS, Vaccination for serogroups A,  C,  W  and  Y  is  routinely
recommended by the Centers for Disease Control and Prevention; and
 
  WHEREAS,  The  Centers for Disease Control and Prevention's Advisory
Committee  on  Immunization  Practices  recommends  that  decisions   to
vaccinate  adolescents  and  young  adults  16  through  23 years of age
against  serogroup  B  meningococcal  disease  should  be  made  at  the
individual  level  with  health  care  providers through shared clinical
decision making; and
 
  WHEREAS, In accordance with ACIP recommendations, Chapter 401 of the
Laws of 2015, requires that as of September 1, 2016, children in  grades
7 through 12 be immunized against meningococcal disease strains A, C, W,
and Y; and
 
  WHEREAS,  New York State Public Health Law (NYS PHL) § 2167 requires
institutions,  including  colleges  and  universities,   to   distribute
information  about meningococcal disease and vaccination to all students
meeting the enrollment criteria, whether they live on or off campus; and
 
  WHEREAS, While New York  State  Law  does  not  require  vaccination
against  serogroup  B meningococcal disease, young adults aged 16-23 may
choose to receive the MenB vaccine series, and are encouraged to discuss
the MenB vaccine with a healthcare provider; and
 
  WHEREAS, Meningitis vaccines  are  covered  by  public  and  private
insurance  plans, and individuals are encouraged to contact their health
insurance plan to determine coverage of MenACWY and MenB vaccines; and
 
  WHEREAS, The federal Vaccines for Children (VFC)  and  NYS  Vaccines
for  Adults (VFA) programs will cover both MenACWY and MenB vaccines for
children and adults  who  have  no  health  insurance  or  whose  health
insurance  does  not  cover these vaccines, as well as for children less
than 19 years of age  who  are  American  Indian  or  Alaska  Native  or
eligible for Medicaid or Child Health Plus; and
 
  WHEREAS,  Kimberly  Coffey  was  17 and a high school senior on Long
Island, who had been vaccinated with the MenACWY,  when  she  died  from
meningitis  B  in  2012,  two  years  before  meningitis B vaccines were
available in the United States; and
 
  WHEREAS,  Kimberly's  mother,  Patti  Wukovits,  R.N.,  created  the
Kimberly Coffey Foundation and today, this  vital  organization  remains
true to its mission in providing education to the public and health care
professionals  about  meningococcal disease and advocating for two types
of meningococcal vaccination; and
 
  WHEREAS, The Kimberly Coffey Foundation's goal is to ensure that  no
other  family  will  endure  the  loss  of  a  child or have a loved one
experience the devastating effects of meningococcal disease; and
 
  WHEREAS, June 15, 2025, marks the thirteenth anniversary of Kimberly
Coffey's death; and
 
  WHEREAS, Students, parents, educators and health care providers need
to know about all strains of meningitis and how to protect  against  all
strains; and
 
  WHEREAS,  A Meningococcal Disease Fact Sheet is available on the New
York State Department of Health website; and
 
  WHEREAS, June is a time when students are preparing to go to college
and can discuss how to become fully vaccinated with  their  health  care
provider; now, therefore, be it
 
  RESOLVED,  That  this Legislative Body pause in its deliberations to
memorialize Governor Kathy Hochul to proclaim June 2025, as Meningitis B
Awareness Month in the State of New York; and be it further
 
  RESOLVED, That copies of this  Resolution,  suitably  engrossed,  be
transmitted  to The Honorable Kathy Hochul, Governor of the State of New
York; and Patti Wukovits,  R.N.,  Executive  Director  of  the  Kimberly
Coffey Foundation.
Go to top